PCRT provides a central resource for patients seeking up-to-date clinical trials; investigators wanting to explore the clinical development of new agents; and biotech and pharma companies seeking strategies and clinical resources. Our comprehensive approach to clinical trial design and implementation includes:

Feasibility studies for investigator interest and patient availability.

Strategy for selection of the right investigators for the trial.

Strong relationships with oncology investigator consortia.

Centralized IRB management.

Medical oncologists to design programs; assist study sites, advise project teams; safety reporting, and provide data interpretation.

Dedicated, specially trained staff with experience recruiting investigators for oncology trials.

The Serum and DNA Bank

A central feature of the PCRT approach is the collection and analysis of serum and DNA (The Serum and DNA Bank) from hundreds of pancreatic cancer patients throughout the world. Currently, there is no such resource available for investigators in the field of pancreatic cancer. The discovery of biomarkers to predict early recurrence of macroscopic disease or recurrent disease could facilitate innovative therapies, when the likelihood of success is higher. This research database, which is made available to PCRT members via a password protected website, allows for the in-depth analysis needed for rapid development of highly targeted therapies. Working collaboratively with PCRT provides researchers with unrivaled access to a worldwide network of clinically-annotated, prospectively consented biological materials from patients with pancreatic cancer.

Clinical Trials

PCRT also initiates and coordinates cancer treatment and chemoprevention studies (Clinical Trials) through a network of physicians at member and affiliated institutions. By partnering relationships with academic, clinical, and corporate entities, PCRT hopes to deliver these discoveries to the patient bedside as improved healthcare interventions. Achievement of this mission is accelerated and empowered through the refinements and breakthroughs in research techniques that span biomedical and genomic methodologies as well as computational biology.